{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T21:39:59Z","timestamp":1769809199227,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10067-025-07916-9","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T18:08:40Z","timestamp":1767636520000},"page":"1069-1078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relapse risk after glucocorticoid withdrawal in stable Sj\u00f6gren\u2019s disease-associated interstitial lung disease: a retrospective cohort study in China"],"prefix":"10.1007","volume":"45","author":[{"given":"Ningxin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8743-7376","authenticated-orcid":false,"given":"Yunyun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"10","key":"7916_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA (2018) Primary Sj\u00f6gren\u2019s syndrome. N Engl J Med 378(10):931\u2013939","journal-title":"N Engl J Med"},{"issue":"1","key":"7916_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","volume":"52","author":"O Palm","year":"2013","unstructured":"Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aal\u00f8kken TM et al (2013) Clinical pulmonary involvement in primary Sjogren\u2019s syndrome: prevalence, quality of life and mortality\u2013a retrospective study based on registry data. Rheumatology (Oxford) 52(1):173\u2013179","journal-title":"Rheumatology (Oxford)"},{"issue":"912","key":"7916_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1259\/bjr\/18937619","volume":"76","author":"N Matsuyama","year":"2003","unstructured":"Matsuyama N, Ashizawa K, Okimoto T, Kadota J, Amano H, Hayashi K (2003) Pulmonary lesions associated with Sj\u00f6gren\u2019s syndrome: radiographic and CT findings. Br J Radiol 76(912):880\u2013884","journal-title":"Br J Radiol"},{"issue":"5","key":"7916_CR4","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1378\/chest.130.5.1489","volume":"130","author":"JG Parambil","year":"2006","unstructured":"Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH (2006) Interstitial lung disease in primary Sj\u00f6gren syndrome. Chest 130(5):1489\u20131495","journal-title":"Chest"},{"issue":"5","key":"7916_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/MD.0b013e3181579781","volume":"86","author":"D Launay","year":"2007","unstructured":"Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M (2007) Pulmonary arterial hypertension: a rare complication of primary Sj\u00f6gren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 86(5):299\u2013315","journal-title":"Medicine (Baltimore)"},{"key":"7916_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0021-2020","author":"F Luppi","year":"2020","unstructured":"Luppi F, Sebastiani M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A (2020) Lung complications of Sjogren syndrome. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0021-2020","journal-title":"Eur Respir Rev"},{"key":"7916_CR7","unstructured":"Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C et al (2020) Interstitial lung disease in Sj\u00f6gren\u2019s syndrome: a clinical review. Clin Exp Rheumatol 38 Suppl 126(4):291\u2013300"},{"key":"7916_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-030-63046-1_12","volume":"1303","author":"RA Peredo","year":"2021","unstructured":"Peredo RA, Beegle S (2021) Sjogren\u2019s syndrome and pulmonary disease. Adv Exp Med Biol 1303:193\u2013207","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"7916_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10067-020-05236-8","volume":"40","author":"X Dong","year":"2021","unstructured":"Dong X, Gao YL, Lu Y, Zheng Y (2021) Characteristics of primary Sj\u00f6gren\u2019s syndrome related lymphocytic interstitial pneumonia. Clin Rheumatol 40(2):601\u2013612","journal-title":"Clin Rheumatol"},{"issue":"15","key":"7916_CR10","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1001\/archinte.168.15.1718","volume":"168","author":"LA Saketkoo","year":"2008","unstructured":"Saketkoo LA, Espinoza LR (2008) Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug. Arch Intern Med 168(15):1718\u20131719","journal-title":"Arch Intern Med"},{"issue":"1","key":"7916_CR11","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.1038\/s41598-023-35608-4","volume":"13","author":"KA Lee","year":"2023","unstructured":"Lee KA, Nam BD, Hwang JH, Kim HS (2023) Clinical course and risk factors for development and progression of interstitial lung disease in primary Sj\u00f6gren\u2019s syndrome. Sci Rep 13(1):9189","journal-title":"Sci Rep"},{"issue":"4","key":"7916_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40520-021-01823-0","volume":"33","author":"OD Messina","year":"2021","unstructured":"Messina OD, Vidal LF, Wilman MV, Bultink IEM, Raterman HG, Lems W (2021) Management of glucocorticoid-induced osteoporosis. Aging Clin Exp Res 33(4):793\u2013804","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"7916_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/MD.0b013e3182a72299","volume":"92","author":"K Migita","year":"2013","unstructured":"Migita K, Sasaki Y, Ishizuka N, Arai T, Kiyokawa T, Suematsu E et al (2013) Glucocorticoid therapy and the risk of infection in patients with newly diagnosed autoimmune disease. Medicine (Baltimore) 92(5):285\u2013293","journal-title":"Medicine (Baltimore)"},{"issue":"16","key":"7916_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1080\/14656566.2016.1232390","volume":"17","author":"MC van der Goes","year":"2016","unstructured":"van der Goes MC, Strehl C, Buttgereit F, Bijlsma JW, Jacobs JW (2016) Can adverse effects of glucocorticoid therapy be prevented and treated? Expert Opin Pharmacother 17(16):2129\u20132133","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"7916_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","volume":"15","author":"M Oray","year":"2016","unstructured":"Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS (2016) Long-term side effects of glucocorticoids. Expert Opin Drug Saf 15(4):457\u2013465","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"7916_CR16","doi-asserted-by":"publisher","first-page":"e1442","DOI":"10.1210\/clinem\/dgad701","volume":"109","author":"A Koning","year":"2024","unstructured":"Koning A, van der Meulen M, Schaap D, Satoer DD, Vinkers CH, van Rossum EFC et al (2024) Neuropsychiatric adverse effects of synthetic glucocorticoids: a systematic review and meta-analysis. J Clin Endocrinol Metab 109(6):e1442\u2013e1451","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"7916_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15284","volume":"27","author":"L Yueting","year":"2024","unstructured":"Yueting L, Lin Q, Jian X, Xinwang D, Yongfu W, Weiguo X et al (2024) Long-term survival analysis of patients with primary Sj\u00f6gren\u2019s syndrome in China: a multicenter retrospective cohort study. Int J Rheum Dis 27(9):e15284","journal-title":"Int J Rheum Dis"},{"issue":"10246","key":"7916_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0140-6736(20)30636-X","volume":"396","author":"GR Burmester","year":"2020","unstructured":"Burmester GR, Buttgereit F, Bernasconi C, \u00c1lvaro-Gracia JM, Castro N, Dougados M et al (2020) Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial. Lancet 396(10246):267\u2013276","journal-title":"Lancet"},{"issue":"2","key":"7916_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/ard-2024-225826","volume":"84","author":"Y Fei","year":"2025","unstructured":"Fei Y, Zhao L, Wu L, Zuo X, Li R, Cheng J et al (2025) Evaluation and prediction of relapse risk in stable systemic lupus erythematosus patients after glucocorticoid withdrawal (PRESS): an open-label, multicentre, non-inferiority, randomised controlled study in China. Ann Rheum Dis 84(2):274\u2013283","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"7916_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/ard-2023-224487","volume":"83","author":"L Peng","year":"2024","unstructured":"Peng L, Nie Y, Zhou J, Wu L, Chen X, Wang F et al (2024) Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial. Ann Rheum Dis 83(5):651\u2013660","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7916_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/annrheumdis-2019-216303","volume":"79","author":"A Mathian","year":"2020","unstructured":"Mathian A, Pha M, Haroche J, Cohen-Aubart F, Hi\u00e9 M, Pineton de Chambrun M et al (2020) Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial. Ann Rheum Dis 79(3):339\u2013346","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7916_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM et al (2017) 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76(1):9\u201316","journal-title":"Ann Rheum Dis"},{"key":"7916_CR23","unstructured":"(2002) American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165(2):277\u2013304"},{"issue":"2","key":"7916_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/rheumatology\/kex077","volume":"57","author":"S Reiseter","year":"2018","unstructured":"Reiseter S, Gunnarsson R, Mogens Aal\u00f8kken T, Lund MB, Mynarek G, Corander J et al (2018) Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study. Rheumatology (Oxford) 57(2):255\u2013262","journal-title":"Rheumatology (Oxford)"},{"key":"7916_CR25","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02718-2020","author":"M Nasser","year":"2021","unstructured":"Nasser M, Larrieu S, Si-Mohamed S, Ahmad K, Boussel L, Brevet M et al (2021) Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study). Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.02718-2020","journal-title":"Eur Respir J"},{"issue":"2","key":"7916_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1055\/s-0034-1371529","volume":"35","author":"M Kreider","year":"2014","unstructured":"Kreider M, Highland K (2014) Pulmonary involvement in Sj\u00f6gren syndrome. Semin Respir Crit Care Med 35(2):255\u2013264","journal-title":"Semin Respir Crit Care Med"},{"issue":"140","key":"7916_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome. Eur Respir Rev 25(140):110\u2013123","journal-title":"Eur Respir Rev"},{"issue":"3","key":"7916_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/thorax-2024-222636","volume":"80","author":"N Srivali","year":"2025","unstructured":"Srivali N, De Giacomi F, Moua T, Ryu JH (2025) Corticosteroid therapy for treating acute exacerbation of interstitial lung diseases: a systematic review. Thorax 80(3):140\u2013149","journal-title":"Thorax"},{"issue":"3","key":"7916_CR29","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.chest.2017.12.010","volume":"153","author":"G Thompson","year":"2018","unstructured":"Thompson G, McLean-Tooke A, Wrobel J, Lavender M, Lucas M (2018) Sj\u00f6gren syndrome with associated lymphocytic interstitial pneumonia successfully treated with tacrolimus and abatacept as an alternative to rituximab. Chest 153(3):e41\u2013e43","journal-title":"Chest"},{"issue":"8","key":"7916_CR30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/RHU.0b013e31823ac199","volume":"17","author":"MA Swartz","year":"2011","unstructured":"Swartz MA, Vivino FB (2011) Dramatic reversal of lymphocytic interstitial pneumonitis in Sj\u00f6gren\u2019s syndrome with rituximab. J Clin Rheumatol 17(8):454","journal-title":"J Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07916-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07916-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07916-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:02:28Z","timestamp":1769763748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07916-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7916"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07916-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Peking Union Medical College Hospital. The ethics approval number is I-23PJ138.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}